Core Factors delivers a suite of type assessments supported by a participant experience designed to sustain learning ...

Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established ...

G-Stacker has announced the availability of its digital infrastructure platform designed to automate the development of interconnected Google properties. The software operates as a technical solution ...

Which are the best software development companies in Cambridge? From IIH Global to Silicon Fen specialists, find your perfect bespoke UK software partner here.

APL is developing a comprehensive suite of capabilities to ensure that additively manufactured parts can perform predictably ...

Understand the impact of IND delays on biotechnology companies and how they affect early-stage development and funding.

“We have 600 petabytes of data across Intel,” said Aziz Safa, corporate VP & GM Intel Foundry Automation at the recent PDF Solutions Users Conference. “The challenge is to be able to run algorithms on ...